Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Baxter

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Endocrinology|January 1, 2004
Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3'-triiodo-L-thyronineGary J Grover, Donald M Egan, Paul G Sleph, et al.
Biochemistry|January 31, 2007
Low-resolution structures of thyroid hormone receptor dimers and tetramers in solutionAna Carolina Migliorini Figueira, Mario de Oliveira Neto, Amanda Bernardes, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 16, 2003
Ligand selectivity by seeking hydrophobicity in thyroid hormone receptorSabine Borngraeber, Mary-Jane Budny, Grazia Chiellini, et al.
Molecular Endocrinology (Baltimore, Md.)|January 30, 2003
Two resistance to thyroid hormone mutants with impaired hormone bindingB Russell Huber, Ben Sandler, Brian L West, et al.
Antiviral Therapy|November 3, 2010
Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation scoreJonathan M Schapiro, Joseph Scherer, Charles A Boucher, et al.
Molecular Endocrinology (Baltimore, Md.)|June 2, 2012
Allosteric conversation in the androgen receptor ligand-binding domain surfacesSolène Grosdidier, Laia R Carbó, Víctor Buzón, et al.
Molecular Endocrinology (Baltimore, Md.)|January 4, 2003
Thyroid hormone receptor-beta mutations conferring hormone resistance and reduced corepressor release exhibit decreased stability in the N-terminal ligand-binding domainB Russell Huber, Marion Desclozeaux, Brian L West, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 5, 2009
Differential effects of TR ligands on hormone dissociation rates: evidence for multiple ligand entry/exit pathwaysSuzana T Cunha Lima, Ngoc-Ha Nguyen, Marie Togashi, et al.
Endocrinology|January 18, 2002
Thyroid hormone export varies among primary cells and appears to differ from hormone uptakeFrancisco A R Neves, Ralph R Cavalieri, Luiz A Simeoni, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2007
The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humansAnders Berkenstam, Jens Kristensen, Karin Mellström, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Endocrinology|January 1, 2004
Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3'-triiodo-L-thyronineGary J Grover, Donald M Egan, Paul G Sleph, et al.
Biochemistry|January 31, 2007
Low-resolution structures of thyroid hormone receptor dimers and tetramers in solutionAna Carolina Migliorini Figueira, Mario de Oliveira Neto, Amanda Bernardes, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 16, 2003
Ligand selectivity by seeking hydrophobicity in thyroid hormone receptorSabine Borngraeber, Mary-Jane Budny, Grazia Chiellini, et al.
Molecular Endocrinology (Baltimore, Md.)|January 30, 2003
Two resistance to thyroid hormone mutants with impaired hormone bindingB Russell Huber, Ben Sandler, Brian L West, et al.
Antiviral Therapy|November 3, 2010
Improving the prediction of virological response to tipranavir: the development and validation of a tipranavir-weighted mutation scoreJonathan M Schapiro, Joseph Scherer, Charles A Boucher, et al.
Molecular Endocrinology (Baltimore, Md.)|June 2, 2012
Allosteric conversation in the androgen receptor ligand-binding domain surfacesSolène Grosdidier, Laia R Carbó, Víctor Buzón, et al.
Molecular Endocrinology (Baltimore, Md.)|January 4, 2003
Thyroid hormone receptor-beta mutations conferring hormone resistance and reduced corepressor release exhibit decreased stability in the N-terminal ligand-binding domainB Russell Huber, Marion Desclozeaux, Brian L West, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 5, 2009
Differential effects of TR ligands on hormone dissociation rates: evidence for multiple ligand entry/exit pathwaysSuzana T Cunha Lima, Ngoc-Ha Nguyen, Marie Togashi, et al.
Endocrinology|January 18, 2002
Thyroid hormone export varies among primary cells and appears to differ from hormone uptakeFrancisco A R Neves, Ralph R Cavalieri, Luiz A Simeoni, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2007
The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humansAnders Berkenstam, Jens Kristensen, Karin Mellström, et al.
Pageof 9